Browse Studies — Arctuva

Observational

Early Feasibility Study of the DUO Transcatheter Tricuspid Coaptation Valve System in Patients With Tricuspid Regurgitation

The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcat…

Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease+1 more

Estimated

~$10 – $8,750

CroiValve LimitedNCT05913908

Observational

A Prospective, Multicenter, Randomized, Controlled Pivotal Trial to Evaluate the Safety and Effectiveness of Transcatheter Tricuspid Valve Repair With the Edwards PASCAL Transcatheter Valve Repair System and Optimal Medical Therapy (OMT) Compared to OMT Alone in Patients With Tricuspid Regurgitation

To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who hav…

Tricuspid RegurgitationTricuspid Valve InsufficiencyTricuspid Valve Disease

Estimated

~$10 – $7,500

Edwards LifesciencesNCT04097145

Observational

VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation

Pivotal trial to evaluate the safety and clinical efficacy of the VDyne System for the treatment of symptomatic severe or greater tricuspid regurgitation.

Tricuspid Valve RegurgitationTricuspid Valve DiseaseCardiovascular Diseases (CVD)+5 more

Estimated

~$10 – $8,750

VDyne, Inc.NCT07516444

Observational

A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation.

Pivotal trial to evaluate the safety and effectiveness of the P\&F TricValve® Transcatheter Bicaval Valve System.

Tricuspid Valve DiseaseHeart Valve DiseasesCardiovascular Diseases+3 more

Estimated

~$10 – $8,750

P+F Products + Features USA Inc.NCT06458907

Observational

CorMatrix® Cor™ TRICUSPID ECM® Valve Replacement Study

The goal of this pivotal study is to demonstrate the safety and performance of the Cor TRICUSPID ECM (extracellular matrix) Valve (or Cor PEDIATRIC Tricuspid E…

Tricuspid Valve DiseaseTricuspid Valve Insufficiency

Estimated

~$10 – $8,750

Corvivo Cardiovascular, Inc.NCT05742906